Americo Padilla
Child & Adolescent Psychiatry · Miami, FLNPI 1174564231
Payments from drug & device makers
Across 325 payments — averaging $5060.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$519K
- Janssen Research & Development, LLC$391K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$210K
- Supernus Pharmaceuticals, Inc.$193K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$123K
- Biohaven Pharmaceutical Holding Company Ltd.$118K
- plus $91K from 18 others
Across 6 payments — averaging $6856.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$41K
- Eli Lilly$414
What the payments were for
- Speaking & faculty fees$5,16048%
- Travel & lodging$9329%
- Food & beverage$4,57343%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 4 | $519,423 |
| Janssen Research & Development, LLC | 43 | $390,780 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $209,880 |
| Supernus Pharmaceuticals, Inc. | 35 | $192,882 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $122,512 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $118,301 |
| Sunovion Pharmaceuticals Inc. | 39 | $36,122 |
| Pfizer | 6 | $29,244 |
| Ironshore Pharmaceuticals Inc. | 51 | $6,873 |
| Rhodes Pharmaceuticals L.p. | 1 | $6,625 |
| Eli Lilly | 4 | $5,123 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 2 | $4,119 |
| Corium, LLC | 35 | $717 |
| Boehringer Ingelheim RCV GmbH & Co KG | 1 | $659 |
| Tris Pharma Inc | 21 | $554 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $423 |
| Shire North American Group Inc | 9 | $265 |
| Otsuka America Pharmaceutical, Inc. | 2 | $140 |
| Vertical Pharmaceuticals, LLC | 4 | $74 |
| Johnson & Johnson | 1 | $36 |
| Alkermes, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$5,764
- LATUDA$820
- Dyanavel XR$191
- JORNAY PM$150
- REXULTI$120
How this compares
$1,644,818 in reported general payments places this provider in the 95th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Other child & adolescent psychiatry in Miami
- Jose AlvarezMiami$229K
- Sean HoranMiami$17K
- Nicole RedondoMiami$4K
- Gilbert SmithMiami$4K
- Jonathan ParkerMiami$4K
- Janeris LoredoMiami$3K
- Jerome SiegmeisterMiami$3K
- Mauricio RodriguezMiami$3K
- Yasin BezMiami$2K
- Elias SarkisGainesville$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.